Cardiovascular Risk
Novo Nordisk Awaits FDA Decision on Oral Wegovy Pill for Obesity
Novo Nordisk; Wegovy; oral semaglutide; FDA approval; obesity treatment; GLP-1 pill; weight loss; cardiovascular risk
Actionable Insights Powered by AI
Novo Nordisk; Wegovy; oral semaglutide; FDA approval; obesity treatment; GLP-1 pill; weight loss; cardiovascular risk